Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.20
Bid: 77.00
Ask: 77.10
Change: 0.00 (0.00%)
Spread: 0.10 (0.13%)
Open: 76.60
High: 77.40
Low: 76.60
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment Completion

1 Dec 2011 10:15

RNS Number : 1538T
GCP Infrastructure Investments Ltd
01 December 2011
 



GCP Infrastructure Investments Limited

(the 'Company')

 

Investment by GCP Infrastructure Fund Limited (the "Master Fund") of a £10.3 million Loan to an Education PFI Project

 

1 December 2011

The Company is a closed-ended investment company that seeks to generate returns from subordinated PFI debt and related and/or similar assets (the "Target Assets"). The Company achieves this by investing substantially all of its capital in the Master Fund, an open-ended investment company that holds the Target Assets. The Company is the majority shareholder of the Master Fund.

The Company is pleased to announce that, on 30 November 2011, the Master Fund advanced a loan of £10.3 million (the "Loan") secured on a subordinated basis against an educational PFI project comprising 3 schools (the "Project"). The Project is located in England and has been operational since 2007. The Loan was advanced to Education PFI Investments Limited ("EPIL") and was financed partly by a credit facility with Royal Bank of Scotland International and partly by available cash reserves. The Loan, which is identified as one of the Expected Imminent Investments in the Company's Prospectus dated 22 November 2011, has a term of c. 23 years and a return of 9.20% p.a. annual equivalent. As detailed in the Company's Prospectus, the Company is targeting a fundraising of £60 million through a Placing and Offer for Subscription of C Shares to take advantage of the investment opportunities that are available to the Master Fund and to repay debt drawn down under the credit facility.

END

 

 

Contact details:

 

Gravis Capital Partners LLP

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

Oriel Securities

Emma Griffin

+44 (0)20 7710 7600

Joe Winkley

Gareth Price

Neil Winward

MHP Communications

Martin Forrest

+44 (0)20 3128 8590

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGGCGPUPGGUG
Date   Source Headline
8th May 20247:00 amRNSInvestor Report at 31 March 2024
26th Apr 20244:53 pmRNSDirector/PDMR Shareholding
26th Apr 20244:51 pmRNSDirector/PDMR Shareholding
26th Apr 20247:00 amRNSWind Disposal and Capital Allocation Policy Update
25th Apr 20247:00 amRNSCompany update, NAV and dividend declaration
20th Feb 20247:00 amRNSRevolving Credit Facility
15th Feb 20244:22 pmRNSDirector/PDMR Shareholding
14th Feb 20241:31 pmRNSResult of Annual General Meeting
2nd Feb 20247:00 amRNSInvestor Report at 31 December 2023
31st Jan 202412:56 pmRNSAnnual Overview from QuotedData
29th Jan 20247:00 amRNSCompany Update, NAV and Dividend Declaration
17th Jan 20249:15 amRNSNotice of Annual General Meeting
16th Jan 20241:53 pmRNSForm 8.3 - [GCP ASSET BACKED INCOME INV TST LTD]
13th Dec 20237:00 amRNSAnnual report and financial statements
12th Dec 20234:15 pmRNSHolding(s) in Company
11th Dec 20234:37 pmRNSHolding(s) in Company
5th Dec 20235:39 pmRNSHolding(s) in Company
30th Nov 20235:35 pmRNSTotal Voting Rights
30th Nov 20234:35 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSInvestor report at 30 September 2023
13th Nov 20237:00 amRNSCompliance with Market Abuse Regulation
10th Nov 20235:07 pmRNSTransaction in Own Shares
6th Nov 20235:30 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSDividend Declaration
31st Oct 20235:14 pmRNSTotal Voting Rights
27th Oct 20235:04 pmRNSTransaction in Own Shares
26th Oct 20235:34 pmRNSTransaction in Own Shares
24th Oct 20235:09 pmRNSTransaction in Own Shares
23rd Oct 20233:30 pmRNSDirector/PDMR Shareholding
23rd Oct 20237:00 amRNSCompany update and net asset value(s)
20th Oct 20235:09 pmRNSTransaction in Own Shares
19th Oct 20235:06 pmRNSTransaction in Own Shares
18th Oct 20235:25 pmRNSTransaction in Own Shares
17th Oct 20235:30 pmRNSTransaction in Own Shares
11th Oct 20235:22 pmRNSTransaction in Own Shares
10th Oct 20235:29 pmRNSTransaction in Own Shares
10th Oct 20237:00 amRNSAppointment of Joint Corporate Broker
9th Oct 20235:22 pmRNSDirector/PDMR Shareholding
4th Oct 20235:31 pmRNSTransaction in Own Shares
3rd Oct 20235:13 pmRNSTransaction in Own Shares
2nd Oct 20234:50 pmRNSTransaction in Own Shares
28th Sep 20235:01 pmRNSTransaction in Own Shares
28th Sep 20234:31 pmRNSHolding(s) in Company
27th Sep 20235:18 pmRNSTransaction in Own Shares
26th Sep 20235:21 pmRNSTransaction in Own Shares
25th Sep 20235:40 pmRNSTransaction in Own Shares
22nd Sep 20235:38 pmRNSTransaction in Own Shares
22nd Sep 20235:35 pmRNSHolding(s) in Company
21st Sep 20235:11 pmRNSTransaction in Own Shares
20th Sep 20235:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.